Breaking News Instant updates and real-time market news.

ACET

Aceto

$1.05

-0.065 (-5.86%)

05:11
02/20/19
02/20
05:11
02/20/19
05:11

Aceto announces proposed sale of chemical business assets for $338M in cash

Aceto announced that it has entered into a "stalking-horse" asset purchase agreement with an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management, to sell its chemicals business assets for gross proceeds of $338 million in cash, plus the assumption of certain liabilities and subject to certain adjustments, on a cash-free and debt-free basis. The sale will be conducted under Section 363 of the U.S. Bankruptcy Code. To facilitate the sale and satisfy its debt obligations, Aceto and its U.S. subsidiaries have filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey. Aceto's foreign chemicals business subsidiaries are not included in the filing but will be included in the sale. In addition, Aceto intends to enter into a stalking horse agreement for its subsidiary, Rising Pharmaceuticals. Aceto expects to complete the dispositions of its chemicals and Rising businesses before its fiscal year end on June 30, 2019. Aceto will operate its business in the ordinary course while it completes the sales of its chemicals business assets and its subsidiary Rising Pharmaceuticals. To that end, Aceto has received a commitment for debtor-in-possession financing of $60 million from a syndicate of lenders led by Wells Fargo Bank, N.A. The DIP financing will finance Aceto's working capital needs through the completion of the sales transactions and support payments to vendors and suppliers for post-petition purchases in the ordinary course. The proposed sales will be conducted through Court-supervised processes under Section 363 of the Bankruptcy Code, subject to Court-approved bidding procedures, potential receipt of higher and better offers at auction and approval by the Court. PJT Partners LP is acting as Aceto's financial advisor and investment banker to lead the sales processes under the bid procedures and Lowenstein Sandler LLP is serving as legal advisor. AP Services, an affiliate of AlixPartners LLP, is also serving as CFO and advisor to the company.

ACET Aceto
$1.05

-0.065 (-5.86%)

04/19/18
ADAM
04/19/18
DOWNGRADE
Target $2
ADAM
Sell
Aceto double downgraded to Sell at Canaccord
As reported previously, Canaccord analyst Dewey Steadman downgraded Aceto two notches, to Sell from Buy, citing a rapid degradation of the company's asset-light business model in the wake of continued pressures for commoditized generics. The company's core human health business has been under significant pressure and has been unable to swiftly adapt to market conditions, said Steadman, who lowered his price target to $2 from $10 on Aceto shares after the company last night said it was suspending further guidance and reducing its dividend.
04/19/18
WELS
04/19/18
NO CHANGE
WELS
Wells says bottom has not been reached in generics pricing
After Aceto (ACET) cited the continued intense competitive and pricing pressures in the generic industry when withdrawing its guidance last night, and Novartis (NVS) this morning reported that net sales at its generic unit Sandoz dropped 4% in the quarter, Wells Fargo analyst Davis Maris says he's not ready to call the bottom in generics pricing. Those that have are premature, Maris tells investors in a research note titled "Negative Read Throughs For Generics Continue." The Aceto and Sandoz pricing news shows the data continue to be negative for U.S. generic industry pricing, the analyst contends. He sees a negative read-through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL).
04/19/18
CHLM
04/19/18
DOWNGRADE
CHLM
Sell
Aceto downgraded to Sell from Hold at Craig-Hallum
04/19/18
04/19/18
DOWNGRADE

Sell
Craig-Hallum downgrades Aceto to Sell after guidance withdrawn, dividend cut
As previously reported, Craig-Hallum analyst Matt Hewitt downgraded Aceto to Sell from Hold after the company last night announced the resignation of its CFO, suspended FY18 guidance, reported asset impairment charges and said it expects to make a "significant reduction" in its dividend. The suspension of guidance and the cut to the dividend suggest the competitive pressures Aceto has been experiencing in oral solids and APIs have worsened, said Hewitt, who believes the company could raise $150M-$200M to reduce its debt balance if it were to sell off the Performance Chemicals segment. Hewitt, who previously had an $8 price target on the stock, removed the target as he awaits visibility on the company's options to stabilize its business.

TODAY'S FREE FLY STORIES

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Conference/Events
UBS to hold a conference »

Future of Retail…

AJG

Arthur J. Gallagher

$88.78

-0.64 (-0.72%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Hot Stocks
Arthur J. Gallagher acquires The Human Capital Group, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$172.68

-4.23 (-2.39%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

, CHWY

Chewy

$26.44

-1.06 (-3.85%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Plus Therapeutics…

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

CHWY

Chewy

$26.44

-1.06 (-3.85%)

ALV

Autoliv

$78.20

-1.06 (-1.34%)

PSTV

Plus Therapeutics

$7.96

-0.34 (-4.10%)

TELL

Tellurian

$8.69

0.105 (1.22%)

RKDA

Arcadia Biosciences

$5.29

-0.23 (-4.17%)

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

AKS

AK Steel

$2.41

-0.05 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 31

    Oct

ABMD

Abiomed

$193.14

0.48 (0.25%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Federal Court of Justice in Germany rules in favor of Abiomed's Impella patents »

The highest court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MU

Micron

$49.17

-0.65 (-1.30%)

08:58
09/23/19
09/23
08:58
09/23/19
08:58
Recommendations
Micron analyst commentary  »

Deutsche comfortable with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

, NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Recommendations
Cirrus Logic, NXP Semiconductors, Texas Instruments analyst commentary  »

Teardown confirms Cirrus…

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

, ROKU

Roku

$107.98

-25.735 (-19.25%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Options
Notable open interest changes for September 23rd »

Friday's total…

NFLX

Netflix

$270.66

-15.92 (-5.56%)

ROKU

Roku

$107.98

-25.735 (-19.25%)

BAC

Bank of America

$29.57

-0.23 (-0.77%)

AAPL

Apple

$217.69

-3.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 16

    Oct

  • 16

    Oct

SABR

Sabre

$23.11

0.12 (0.52%)

08:54
09/23/19
09/23
08:54
09/23/19
08:54
Hot Stocks
Sabre signs long-term agreement with Magnum Travel Services »

Sabre announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$156.29

-0.66 (-0.42%)

08:53
09/23/19
09/23
08:53
09/23/19
08:53
Recommendations
Dollar General analyst commentary  »

Dollar General price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 30

    Sep

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

08:51
09/23/19
09/23
08:51
09/23/19
08:51
Downgrade
Cleveland-Cliffs rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

INPX

Inpixon

$0.13

0.0013 (0.98%)

08:50
09/23/19
09/23
08:50
09/23/19
08:50
Hot Stocks
Inpixon's Jibestream signs teaming agreement with IDENTOS »

Jibestream announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/23/19
09/23
08:50
09/23/19
08:50
General news
NY Fed's repo results: Fed's repo totaled $65.75 B »

NY Fed's repo…

CGNX

Cognex

$48.20

-2.28 (-4.52%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Recommendations
Cognex analyst commentary  »

Cognex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$21.70

-0.26 (-1.18%)

, X

U.S. Steel

$10.81

-0.25 (-2.26%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Downgrade
Alcoa, U.S. Steel, Commercial Metals, Nucor, Steel Dynamics, Stelco Holdings rating change  »

JPMorgan double…

AA

Alcoa

$21.70

-0.26 (-1.18%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

NUE

Nucor

$52.62

-0.08 (-0.15%)

STLD

Steel Dynamics

$30.38

-0.32 (-1.04%)

STZHF

Stelco Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Hot Stocks
Abeona recieves clinical hold letter from FDA over Phase 3 trial for EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FNB

F.N.B.

$11.38

-0.045 (-0.39%)

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
F.N.B. announces $150M stock repurchase program »

F.N.B. announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
Resverlogix to present BETonMACE trial results at AHA Scientific Sessions »

Resverlogix announced the…

PRSP

Perspecta

$26.29

-0.005 (-0.02%)

08:46
09/23/19
09/23
08:46
09/23/19
08:46
Hot Stocks
Perspecta awarded $657M extension of NGEN contract with U.S. Dept. of Navy »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Hot Stocks
Apple partners with Oprah Winfrey to bring Oprah's Book Club to Apple »

Apple and Oprah Winfrey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$155.23

0.19 (0.12%)

, HEXO

HEXO Corp

$4.37

0.425 (10.79%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BYND

Beyond Meat

$155.23

0.19 (0.12%)

HEXO

HEXO Corp

$4.37

0.425 (10.79%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

ABBV

AbbVie

$72.46

0.78 (1.09%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

COTY

Coty

$10.17

-0.1 (-0.97%)

ADI

Analog Devices

$115.30

-0.72 (-0.62%)

NOK

Nokia

$5.30

0.145 (2.81%)

IMMU

Immunomedics

$16.60

-0.44 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Nov

08:45
09/23/19
09/23
08:45
09/23/19
08:45
General news
U.S. Chicago National Activity index rose 0.51 points to 0.10 in August »

U.S. Chicago National…

NTGR

Netgear

$30.67

0.64 (2.13%)

08:44
09/23/19
09/23
08:44
09/23/19
08:44
Hot Stocks
Netgear joins Open Security and Safety Alliance »

NETGEAR announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$18.85

(0.00%)

08:42
09/23/19
09/23
08:42
09/23/19
08:42
Recommendations
L Brands analyst commentary  »

Jefferies reiterates call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 21

    Nov

MU

Micron

$49.17

-0.65 (-1.30%)

08:42
09/23/19
09/23
08:42
09/23/19
08:42
Recommendations
Micron analyst commentary  »

Morgan Stanley says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.